🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Increased incidence in radiation ☢️ necrosis when delivered 7 days before to 21 days after ADC. Symptomatic Necrosis With ADCs and Concurrent Stereotactic Radiotherapy for Brain Metastases | Targeted and Immune Cancer Therapy | JAMA Oncology #bcsm jamanetwork.com/journals/jamao…

Join our Lunch and Learn during Lung Cancer Awareness Month! This is a hybrid event to discuss the latest in #lungcancerresearch and treatment with focus on empowering one to live well with lung cancer. Jennifer Carlisle Suresh S. Ramalingam, MD, FASCO Winship Cancer Institute of Emory University Emory School of Medicine

#Lung Cancer is an equal opportunity disease. Learn the facts about women and lung cancer: LCRF.org/women

Watch a clip from our recent webinar to hear Jennifer Carlisle highlight the importance of #biomarker testing for personalized #NSCLC care. Learn more about #biomarkertesting on the #NoOneMissed site: no1missed.org/4aiPRa8 #LCSM

Lung cancer is largely a radiographic diagnosis. Ordering liquid bx prior to tissue confirmation accelerates timeline to treatment. Important for early and late stage disease. Thank you for the great collaboration! Geoff Oxnard MD Christian Rolfo Bruna Pellini, MD #ngs #liquidbiopsy

Check out our latest paper “Differentiation fate of a stem-like CD4 T cell control immunity to cancer”, led by Maria Andrea Cardenas now live nature tinyurl.com/33d24k89 . This work examines how CD4 T cell differentiation dictates the outcome of the cancer response. Thread below

Oral propranolol 10mg tid to treat amivantamab induced scalp ulcers in #EGFR NSCLC Lung Cancer Journal. Possible mechanisms: vasoconstriction, reducing VEGF and bFGF, promoting apoptosis of endothelial cells, hemangioma-derived stem cells, and pericytes. lungcancerjournal.info/article/S0169-…

Can’t help but notice 8/10 are indicated in lung cancer!

This is a very effective data visualization.

Report on NGS in squamous NSCLC Lung Cancer Journal from Dr. Joshua Reuss et al. Detected actionable genomic alterations in 22.2% of patients with squamous NSCLC and no history of smoking including #EGFR and #MET. In those with prior smoking, AGAs in 2.4%. lungcancerjournal.info/article/S0169-…

🔥Cancer🆙 ✅DeLLphi-301: Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer 👥Jacob sands #LCSM OncoAlert acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Happy to share our recent ESMO Open paper on the #safety and #feasibility of #outpatient administration of #tarlatamab as part of the #DeLLphi300 study providing evidence that support less intensive monitoring at initiation of therapy. #LCSM 🫁 #SCLC Luis Paz-Ares Noemi Reguart

I enthusiastically endorse Ticiana Leal for the IASLC board of directors undesignated seat#3. She is a tireless advocate for patients, expert in designing clinical trials and a truly phenomenal mentor and sponsor. Voting is open through May 22!

It has been a true privilege to attend today’s lecture by Prof. Ahmed, hosted by UNIGE_en. We are extremely fortunate to have had the chance to learn from one of the world’s foremost experts in T cells and immunotherapy. A huge thank you to UNIGE_en Annapaola Mariniello

#Aboutlastnight Traditional dinner of the #EAOnc Thoracic Core Committee during the Spring meeting in Tampa. #teamscience #researchmatters ECOG-ACRIN Cancer Research Group

🔔‼️Next Sunday June 1 ASCO⁩ , don’t forget to mark your calendars and join ⁦Jennifer Carlisle⁩ ⁦Melissa L. Johnson⁩ #MelindaHsu and myself to discuss about T-cell engagers Amivantamab and more! I will be talking about Bispecific T cell engagers, current and future!

✅ ‼️ Now online ASCO EduBook article led by Jennifer Carlisle and others from our upcoming Education session June 2. We discuss novel Bispecifics Abs in #NSCLC and Tox management approaches. Sagal Pannu Ayesha Aijaz. Have a read !

#ASCO25 ASCO Education Book has incredible resources in #LungCancer #LCSM ADCs in #NSCLC Rafeh Naqash, MD Jennifer Carlisle Melissa L. Johnson and others! OncoAlert

‼️Excited to share our ASCO edu book article on DLL3 targeting in SCLC. Probably one of the most extensive and Upto date reviews on this topic! Led by Ayesha Aijaz Sagal Pannu We talk about biology, trials, other T cell engagers , tox and much more! ascopubs.org/doi/10.1200/ED…

🎉 Congratulations to Jennifer Carlisle an outstanding #ASCO25 talk! 🎯 Objective: To optimize the clinical use of amivantamab in NSCLC and provide strategies for managing its dermatologic adverse events. 📊 Key Study Highlights: – EGFR Exon20: CHRYSALIS, PAPILLON – Classical